PL3638278T3 - Kompozycje neuroprotekcyjne i ich zastosowanie - Google Patents

Kompozycje neuroprotekcyjne i ich zastosowanie

Info

Publication number
PL3638278T3
PL3638278T3 PL18817403.1T PL18817403T PL3638278T3 PL 3638278 T3 PL3638278 T3 PL 3638278T3 PL 18817403 T PL18817403 T PL 18817403T PL 3638278 T3 PL3638278 T3 PL 3638278T3
Authority
PL
Poland
Prior art keywords
neuroprotective compositions
neuroprotective
compositions
Prior art date
Application number
PL18817403.1T
Other languages
English (en)
Inventor
Muhammed Majeed
Kalyanam Nagabhushanam
Original Assignee
Sami-Sabinsa Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sami-Sabinsa Group Limited filed Critical Sami-Sabinsa Group Limited
Publication of PL3638278T3 publication Critical patent/PL3638278T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL18817403.1T 2017-06-15 2018-06-15 Kompozycje neuroprotekcyjne i ich zastosowanie PL3638278T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762520141P 2017-06-15 2017-06-15
PCT/US2018/037724 WO2018232224A1 (en) 2017-06-15 2018-06-15 Neuroprotective compositions and their use

Publications (1)

Publication Number Publication Date
PL3638278T3 true PL3638278T3 (pl) 2022-10-03

Family

ID=64655980

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18817403.1T PL3638278T3 (pl) 2017-06-15 2018-06-15 Kompozycje neuroprotekcyjne i ich zastosowanie

Country Status (7)

Country Link
US (2) US11458117B2 (pl)
EP (2) EP3638277A4 (pl)
JP (2) JP7209645B2 (pl)
KR (2) KR20190134809A (pl)
CA (2) CA3063751C (pl)
PL (1) PL3638278T3 (pl)
WO (2) WO2018232063A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3638277A4 (en) * 2017-06-15 2021-03-17 Sami Labs Limited COMPOSITIONS AND PROCEDURES FOR INHIBITING BETA SECRETASE
CN110115712A (zh) * 2019-07-04 2019-08-13 兰州大学 一种同时激活氧化磷酸化通路和抑制糖酵解途径的激活剂及其应用
EP4021397A4 (en) * 2019-08-26 2023-09-27 Sami-Sabinsa Group Limited HERBAL ACTIVE INGREDIENTS AND THEIR EFFECT AGAINST POLLUTION
CN114246879B (zh) * 2021-12-30 2023-10-27 沈阳兴齐眼药股份有限公司 木蝴蝶苷b在制备用于预防、控制和/或治疗眼部疾病药物中的用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7514469B2 (en) * 2002-04-30 2009-04-07 Unigen Pharmaceuticals, Inc. Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent
US8945518B2 (en) * 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
US8034387B2 (en) * 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
RU2392957C2 (ru) 2003-09-02 2010-06-27 Юниджен Фармасьютиклз, Инк. Композиция, содержащая смесь флавоноидов со свободным кольцом и флаванов, которая предназначена для предупреждения и лечения ухудшения когнитивной способности и связанных с возрастом ослаблений памяти
WO2007080484A2 (en) * 2006-01-09 2007-07-19 Council Of Scientific & Industrial Research Flavonoids isolated from oroxylum indicum for treatment of gastrointestinal toxicity, associated symptoms and ulcers
WO2007096739A2 (en) * 2006-02-21 2007-08-30 Council Of Scientific And Industrial Research Intestinal alpha-glucosidase inhibitors and a process for the isolation and use thereof
EP2007385A4 (en) 2006-03-23 2010-08-18 Sinai School Medicine CARDIOVASCULAR COMPOSITION AND ITS USE FOR THE TREATMENT OF MORBUS ALZHEIMER
KR20080008929A (ko) * 2006-11-20 2008-01-24 대한민국(관리부서 식품의약품 안전청장) 오록실린 ａ를 함유하는 인지 기능 장애 관련 질환의 예방및 개선용 건강기능식품
BR112015004418A2 (pt) * 2012-08-29 2017-07-04 Mannkind Corp composição de pó seco inalável, sistema de liberação de fármaco, processo para formar uma partícula e kit.
WO2018089325A1 (en) * 2016-11-11 2018-05-17 Muhammed Majeed Composition containing oroxylin a and method of extraction thereof
EP3638277A4 (en) 2017-06-15 2021-03-17 Sami Labs Limited COMPOSITIONS AND PROCEDURES FOR INHIBITING BETA SECRETASE

Also Published As

Publication number Publication date
JP6796217B2 (ja) 2020-12-02
EP3638278A1 (en) 2020-04-22
JP2020523372A (ja) 2020-08-06
EP3638277A4 (en) 2021-03-17
WO2018232224A1 (en) 2018-12-20
EP3638278A4 (en) 2021-03-17
CA3063751A1 (en) 2018-12-20
US20180360800A1 (en) 2018-12-20
EP3638278B1 (en) 2022-05-11
CA3063757C (en) 2023-08-01
JP2020523342A (ja) 2020-08-06
KR20190134809A (ko) 2019-12-04
US11458117B2 (en) 2022-10-04
US10894029B2 (en) 2021-01-19
CA3063751C (en) 2023-01-03
CA3063757A1 (en) 2018-12-20
US20180360801A1 (en) 2018-12-20
KR20190131589A (ko) 2019-11-26
EP3638277A1 (en) 2020-04-22
JP7209645B2 (ja) 2023-01-20
WO2018232063A1 (en) 2018-12-20

Similar Documents

Publication Publication Date Title
IL268828A (en) products and vehicles
IL271275A (en) Preparations containing coronas and their uses
IL272232A (en) GLP-1 compounds and their uses
SI3580561T1 (sl) Metode, osnovane na hla, in njihove sestave ter uporabe
IL269576A (en) products and vehicles
IL269517A (en) compounds and products
PL3638278T3 (pl) Kompozycje neuroprotekcyjne i ich zastosowanie
SG11202002224XA (en) Composition and uses thereof
IL277663A (en) Arunumab preparations and their uses
GB201807576D0 (en) Compositions and uses thereof
GB201712592D0 (en) Novel compositions and uses thereof
GB201821138D0 (en) Compositions and uses thereof
GB201812334D0 (en) Compositions and uses thereof
GB2607546B (en) Functional composition and uses thereof
GB201812952D0 (en) Compositions and uses thereof
IL252660B (en) Compounds characterized by an inverse freezing property and their uses
GB201715730D0 (en) Chitin-chitosanhydrogel compositions and their uses
GB201821144D0 (en) Compositions and uses thereof
GB201819493D0 (en) Compositions and uses thereof
GB201818495D0 (en) Compositions and uses thereof
GB201818375D0 (en) Compositions and uses thereof
GB201808907D0 (en) Compositions and uses thereof
GB201808858D0 (en) Compositions and uses thereof
GB201808321D0 (en) Compositions and uses thereof
GB201808298D0 (en) Compositions and uses thereof